Related Experiment Videos

Molecular markers for the prediction of progression of CIN lesions

Lindsey J Gray, C Simon Herrington

International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists

|April 16, 2004

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.

Nature communications·2025

Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer.

European journal of cancer (Oxford, England : 1990)·2025

Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma.

Gynecologic oncology·2025

Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma.

European journal of cancer (Oxford, England : 1990)·2025

See all related articles